InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Beginning Cash Balance (2017 - 2026)

InflaRx (IFRX) posted Beginning Cash Balance of $18.8 million for Q1 2026, down 2.96% sequentially from $19.3 million in Q1 2025, and down 2.96% YoY from $19.3 million in Q1 2025.

InflaRx (IFRX) Beginning Cash Balance (2017 - 2026) Analysis & Trends

InflaRx has reported Beginning Cash Balance for 10 years, with the latest figure at $18.8 million in Q1 2026.

  • Quarterly Beginning Cash Balance fell 2.96% year-over-year to $18.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.8 million (down 2.96% YoY) and the FY2025 annual result came in at $20.8 million, up 50.24% from the prior year.
  • Beginning Cash Balance eased to $18.8 million in Q1 2026 per IFRX's latest filing, from $19.3 million in the prior quarter.
  • Over five years, Beginning Cash Balance peaked at $29.5 million in Q1 2022 and troughed at $13.9 million in Q1 2024.
  • A 5-year average of $19.8 million and a median of $18.8 million in 2026 frame the typical range for Beginning Cash Balance.
  • The sharpest annual moves came in 2023 and 2025: Beginning Cash Balance sank 40.74% in 2023, then soared 39.36% in 2025.
  • Over 5 years, Beginning Cash Balance stood at $29.5 million in 2022, then sank by 40.74% to $17.5 million in 2023, then decreased by 20.55% to $13.9 million in 2024, then jumped by 39.36% to $19.3 million in 2025, then fell by 2.96% to $18.8 million in 2026.
  • According to Business Quant data, Beginning Cash Balance over the past three periods registered $18.8 million, $19.3 million, and $13.9 million for Q1 2026, Q1 2025, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.76 Mn
Mar 31, 2026 18.76 Mn
Mar 31, 2025 19.33 Mn
Mar 31, 2025 19.33 Mn
Mar 31, 2024 13.87 Mn
Mar 31, 2024 13.87 Mn
Mar 31, 2023 17.46 Mn
Mar 31, 2023 17.46 Mn
Mar 31, 2022 29.46 Mn
Mar 31, 2022 29.46 Mn
Mar 31, 2021 31.32 Mn
Mar 31, 2021 31.32 Mn
Mar 31, 2020 36.57 Mn
Mar 31, 2020 36.57 Mn
Mar 31, 2019 62.95 Mn
Mar 31, 2019 62.95 Mn
Sep 30, 2018 -130.27
Sep 30, 2018 -130.27
Mar 31, 2018 151.46 Mn
Mar 31, 2018 151.46 Mn